MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-05-2023
Heska Corporation ROA Ratio 2011-2026 | HSKA
Annual ROA Ratio Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.4 | -0.19 | -3.6 | -0.6 | 3.74 | 7.33 | 8.03 | 4.77 | 2.69 | -1.28 | 1.8 | 3.47 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.03 | -3.6 | 1.9 |
Quarterly ROA Ratio Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.76 | -2.63 | -4.28 | -4.52 | -3.96 | -1.97 | -1.62 | -2.61 | -3.87 | -4.22 | -4.92 | -3.75 | -2.25 | -0.6 | 2.32 | 1.38 | 2.69 | 3.74 | 0.73 | 4.07 | 5.31 | 7.33 | 10.76 | 11.04 | 10.52 | 8.03 | 7.24 | 5.97 | 5.14 | 4.77 | 3.78 | 3.02 | 3.03 | 2.69 | 3.09 | 2.82 | -0.67 | -1.28 | -1.95 | -2.26 | 0.51 | 1.8 | 2.0 | 2.51 | 2.86 | 3.47 | 0.47 | 0.74 | 1.48 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11.04 | -4.92 | 1.53 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
3.33 | $ 9.2 | 2.17 % | $ 613 M |  USA |
|
Biodesix
BDSX
|
-44.15 | $ 15.36 | 4.56 % | $ 1.99 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.14 | 0.47 % | $ 4.92 M | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 16.25 | -0.49 % | $ 491 M | USA |
 |
Guardant Health
GH
|
-20.67 | $ 83.44 | -1.79 % | $ 10.5 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 102.22 | 1.86 % | $ 8.43 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
31.62 | $ 572.04 | -1.12 % | $ 46 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 74.38 | -1.79 % | $ 5.02 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
 |
Medpace Holdings
MEDP
|
22.84 | $ 463.54 | 1.45 % | $ 13.4 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.67 | 0.11 % | $ 432 M | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 17.35 | -0.91 % | $ 388 M | USA |
 |
Pacific Biosciences of California
PACB
|
-69.68 | $ 1.39 | -0.36 % | $ 417 M | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Precipio
PRPO
|
-32.34 | $ 27.01 | 0.3 % | $ 35.1 M | USA |
 |
Personalis
PSNL
|
-30.08 | $ 7.71 | 1.31 % | $ 457 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
RadNet
RDNT
|
-0.5 | $ 59.66 | -3.37 % | $ 4.49 B | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 159.73 | 1.09 % | $ 7.92 B | USA |
 |
IQVIA Holdings
IQV
|
4.54 | $ 165.68 | -0.77 % | $ 28.5 B | USA |
 |
Sotera Health Company
SHC
|
2.39 | $ 13.83 | -0.36 % | $ 3.93 B | USA |
 |
Soleno Therapeutics
SLNO
|
3.71 | $ 31.01 | -2.24 % | $ 1.58 B | USA |
 |
Neuronetics
STIM
|
-27.55 | $ 1.45 | -9.69 % | $ 95.6 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-35.87 | $ 1.23 | -15.75 % | $ 6.7 M | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 263.12 | 1.94 % | $ 26 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
45.31 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 125.57 | 1.44 % | $ 20 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 46.42 | 4.31 % | $ 2.78 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 101.62 | -4.81 % | $ 4.01 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 267.18 | 1.04 % | $ 22.2 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 3.49 | 0.29 % | $ 1.87 M | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 7.91 | -2.41 % | $ 1.01 B | USA |
 |
Natera
NTRA
|
-39.28 | $ 194.73 | -2.68 % | $ 19.2 B | USA |
 |
Senseonics Holdings
SENS
|
-54.73 | $ 6.62 | - | $ 276 M | USA |